Clinical Trial Update: A Woman Suffered From Leukocytopenia and Widespread Migration After Polyacrylamide Hydrogel (PAAG) Injection in Epicranial Aponeurosis

View source ↗

Summary

A trial participant developed leukocytopenia and migration of polyacrylamide hydrogel after PAAG injection into the epicranial aponeurosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukocytopenia

Drugs mentioned

• Polyacrylamide hydrogel (PAAG) (polyacrylamide hydrogel)

Snippet

Sponsor: Duo Zhang | Conditions: Complication | Status: COMPLETED